Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting

Datos Bibliográficos

ID4615368
AutoresM V Uthaug (0000-0001-7903-1325, Maastricht University, autor de correspondencia), R Lancelotta (InnatePath,Lakewood), Rafaelle L Lancelotta (0000-0002-7789-3463), Ana María Ortiz Bernal (0000-0003-3304-6497, University of Wisconsin–Madison), A K Davis (0000-0003-4770-8893, Johns Hopkins University), Johannes G Ramaekers (0000-0003-4553-376X, Maastricht University)
Año2020
Volumen4
Número2
Páginas104-113
Fecha de publicación2020-06-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaJournal of Psychedelic Studies (JOURNAL)
Identificadores de la revistaISSN: 2559-9283 • E-ISSN: 2559-9283
EditorialAkademiai Kiado Zrt (PUBLISHER)
DOI10.1556/2054.2020.00123
OpenAlexW3013834281
IdiomaEN
Citas recibidas6
Referencias citadas43

BackgroundPrevious research suggests a therapeutic potential of5-methoxy-N,N-dimethyltryptamine(5-MeO-DMT). However, online anecdotal reports have described a phenomenon following cessation of the acute effects of 5-MeO-DMT use which has been termedreactivation(i.e., re-experiencing ["flashback"]). To date, no research has investigated whether different routes of administration may confer different reactivation rates, effects and experiences.AimsWe aimed to assess whether intramuscular injection (IM) and vaporization of 5-MeO-DMT conferred different reactivation rates, changes in satisfaction with life as well as ratings of the experience with ego dissolution and the mystical.MethodsUsing internet-based advertisements, 27 respondents (Mage= 32. SE = 1.43; males = 18; North America = 19) completed an online-based survey.ResultsOf the 14 participants in the IM group, 3 (21%) reported reactivations; in contrast, of the 13 participants in the vaporization group, 9 (69%) reported reactivations. Redosing (more than 1 dose) occurred more frequently in the vaporization group (N= 8) (1-6 times with 3-35 mg of 5-MeO-DMT), relative to the IM group (N= 2) (1-5 times with 5-10 mg of 5-MeO-DMT). All participants in the IM group experienced release of physical tension, compared to 8 participants in the vaporization group. Participants in the IM group reported longer time of onset of acute effects (between 1 and 3 [N= 6] and 4-6 min [N= 6]), relative to the vaporization group where the majority (N= 11) reported a rapid onset of 1-50 s.ConclusionFindings suggest that compared to vaporization, the IM route of administering 5-MeO-DMT is associated with lower and less doses, lower frequencies of reporting reactivation, a higher frequency of physical tension release, and a slower onset of acute effects

Anesthesia · Hallucinogen · Psychiatry · Vaporization · Body Image and Dysmorphia Studies · Chemistry · Complementary and Alternative Medicine Studies · Medicine · Psychedelics and Drug Studies · Psychology

  • Exploring the importance of bodyset for the psychedelic experience and beyond

    Open Access•M V Uthaug, Giancarlo Allocca et al.•Journal of Psychedelic Studies•2025

  • MeO-DMT for post-traumatic stress disorder

    Open Access•Anya Ragnhildstveit, Ryan Khan et al.•Frontiers in Psychiatry•2023

  • Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings

    Open Access•Ana María Ortiz Bernal, Charles L Raison et al.•Frontiers in Psychiatry•2022

  • Defining 5-MeO-DMT in Historical and Cultural Contexts

    Azul DelGrasso•World Futures•2024

  • Commentary

    Kelan Thomas, Robert Jesse et al.•Journal of Psychoactive Drugs•2024

  • A Scoping Review of Research in Naturalistic Studies with Psychedelics

    Open Access•Laura C Carvalho, Jorge Encantado et al.•Journal of Psychoactive Drugs•2025

  • Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

    Open Access•Frederick S Barrett, Matthew W Johnson et al.•Journal of Psychopharmacology•2015

  • Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction

    Albert Garcia-Romeu, Albert Garcia‐Romeu et al.•Current Drug Abuse Reviewse•2015

  • Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

    Open Access•Leor Roseman, David Nutt et al.•Frontiers in Pharmacology•2018

  • Ego-Dissolution and Psychedelics

    Open Access•Matthew M Nour, Lisa Evans et al.•Frontiers in Human Neuroscience•2016

  • Recall bias in epidemiologic studies

    Open Access•Steven S Coughlin•Journal of Clinical Epidemiology•1990

  • Predicting Responses to Psychedelics

    Open Access•Eline C H M Haijen, Eline Haijen et al.•Frontiers in Pharmacology•2018

  • Constructing drug effects

    Open Access•Ido Hartogsohn•Drug Science, Policy and Law•2017

  • Set and setting, psychedelics and the placebo response

    Open Access•Ido Hartogsohn•Journal of Psychopharmacology•2016

  • Psychedelics and the essential importance of context

    Open Access•Robin L Carhart-Harris, Leor Roseman et al.•Journal of Psychopharmacology•2018

  • The Satisfaction With Life Scale

    Ed Diener, Robert A Emmons et al.•Journal of Personality Assessment•1985

  • Über Die Synthese Des Bufotenin-Methyl-Äthers (5-Methoxy-N-Dimethyl-Tryptamin) Und Bufotenins (Synthesen in Der Indol-Gruppe. Xv)

    Open Access•Toshio Hoshino, Kenya Shimodaira•Bulletin of the Chemical Society…•1936

  • Response expectancy as a determinant of experience and behavior

    Irving Kirsch•American Psychologist•1985

  • Bufo alvarius

    Open Access•Andrew Weil, Andrew T Weil et al.•Journal of Ethnopharmacology•1994

  • Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being

    Open Access•Natasha L Mason, Elisabeth Mischler et al.•Journal of Psychoactive Drugs•2019

  • Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner

    Michael Lyvers, Molly Meester•Journal of Psychoactive Drugs•2012

  • Conditioning, Expectancy, and the Placebo Effect

    Irving Kirsch•Psychological Bulletin•2004

  • Factor Analysis of the Mystical Experience Questionnaire

    Open Access•Katherine A Maclean, Jeannie‐marie S Leoutsakos et al.•Journal for the Scientific Study…•2012

Obras citantes distintas6
Citas por año1,5
Intervalo de citas2022 - 2025 (4)
Velocidad de citaciónrecent
Altamente citadoNo
Tipos de citaNeutras: 5
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae